A new class of injectable material that stimulates stem cells to regenerate damaged tissue and form new blood vessels, heart and bone tissue is being developed by an international team of researchers. The aim is to produce radical new treatments that will reduce the need for invasive surgery, optimize recovery and reduce the risk of undesirable scar tissue.